
A group extends a hand to those affected by breast or reproductive cancers, especially younger previvors, patients and caregivers.

A group extends a hand to those affected by breast or reproductive cancers, especially younger previvors, patients and caregivers.

Can mastectomy or lumpectomy be avoided in women with ductal carcinoma in situ?

CAR-T cell therapy is drastically improving outcomes for patients with diffuse large B-cell lymphoma. However, the treatment can come with some severe side effects that patients need to know about.

Helping underserved women at the community level can be a crucial step toward reducing deaths from late-stage breast cancer. A grassroots initiative in Florida aims to contribute to that change and inspire the formation of similar groups.

On social media, CURE® recently asked its readers to share how cancer has affected their careers.

Organized as a virtual event, the DONNA Foundation’s 2021 National Marathon to Finish Breast Cancer will allow participants to run in their neighborhoods — or on their treadmills.

Oncology nurses become family not just with one another, but their patients as well.

How does a metastatic cancer diagnosis affect families, especially children? CURE® spoke with Kate Watson, a patient ambassador for METAvivor, about the tricky balance of protecting and empowering kids.

On the cancer journey, oncology nurses are more than just a helping hand. They can be your second "mom" and guide you through the confusing parts.

Just one week of radiation therapy after surgery for early-stage breast cancer is as safe and effective as longer courses, researchers report.

An oncology nurse, patient turned advocate and cancer biologist were honored during CURE®’s third annual Ovarian Cancer Heroes program where they got to share messages of resiliency with a virtual audience.

After granting accelerated approval in 2018, the Food and Drug Administration approved Venclexta in combination with Vidaza, Dacogen or low dose cytarabine in newly diagnosed patients with AML.

A study evaluating the efficacy of Aliqopa (copanlisib) in combination with Rituxan (rituximab) in patients with indolent non-Hodgkin’s lymphoma who have relapsed after at least one prior line of therapy also involving Rituxan has met its primary endpoint, according to Aliqopa’s manufacturer, Bayer.

From “The Wanted” singer Tom Parker announcing he has been diagnosed with stage 4 glioblastoma and is undergoing treatment, to a Houston-area father receiving treatment for leukemia surprising his daughter on her wedding day, here’s what’s happening in the cancer landscape this week.

Two physicians, a nurse and a patient advocate were honored during CURE®’s first ever Lung Cancer Heroes program.

Men may experience erectile dysfunction and incontinence after receiving treatment for prostate cancer. However, there are devices — like a penile prosthetic and artificial urinary sphincter — that can help control those side effects associated with treatment.

Through Bristol Myers Squibb’s ‘Survivorship Today,’ Brown — a star of the TV series “This Is Us” — has been interviewing cancer survivors about their journeys and the kinds of support they need.

Data from the trial that led to the FDA approval demonstrated that Keytruda reduced the risk of progression or death in patients with relapsed or refractory classical Hodgkin lymphoma by 35%, compared to Adcetris.

The average overall survival for patients who reported consuming four or more cups of coffee per day prior to trial enrollment was 39 months.

Prostate cancer treatment can be detrimental to bone and muscle health, but an exercise regimen and healthy eating habits can help.

In an interview with CURE®, Dr. Trisha Wise-Draper discusses new findings that show an increased mortality risk for patients with cancer receiving systemic treatments who subsequently contracted COVID-19.

Researchers found that neoadjuvant chemotherapy with intense dose-dense Ellence (epirubicin), Taxol (paclitaxel), and Cytoxan (cyclophosphamide) (iddEPC) demonstrated significant disease-free survival benefits in the treatment of patients with HR+/HER2- breast cancer.

Everyone has a role to play in decreasing Clostridioides difficile infection rates on oncology units, recent research shows.

For Metastatic Breast Cancer Awareness Day on Oct. 13, 2020, here’s a round-up of fast facts and the latest news and updates in this disease space.

Combining the immunotherapy Keytruda with a CAR-T cell therapy that targets the proteins CD19 and CD22 generates complete responses with minimal side effects, results from an early study demonstrate.

Some patients are better suited for surgery than others. In general, patients with widespread metastatic disease are also not good candidates for surgery, particularly if their cancer has spread beyond the prostate to areas like the liver, lungs, and bones.

On social media, CURE® recently asked its readers to share their thoughts on the month of “Pinktober”.

Active surveillance can be used for many patients with prostate cancer; however, when localized, radiation therapy is an option.

In this essay, a patient with cancer shares how her oncology nurse was a true comfort through the cancer journey and a true friend.

One patient talks about how their oncology nurse was a hero to not just her, but many other patients in the clinic.